Tarsus Pharmaceuticals Inc (TARS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,724 | 96,648 | 175,787 | 94,819 | 176,210 |
| Marketable Securities | 289,113 | 284,495 | 232,129 | 196,557 | 140,742 |
| Receivables | 74,336 | 60,240 | 64,153 | 48,059 | 30,304 |
| Inventories | 3,836 | 3,873 | 2,705 | 2,620 | 2,846 |
| TOTAL | $501,704 | $474,429 | $480,773 | $356,705 | $357,117 |
| Non-Current Assets | |||||
| PPE Net | 5,746 | 3,182 | 2,787 | 2,314 | 2,393 |
| Investments And Advances | 3,000 | 3,000 | 3,000 | 3,000 | 3,000 |
| Intangibles | 7,606 | 7,846 | 8,086 | 8,326 | 8,567 |
| Other Non-Current Assets | 16,505 | 6,537 | 6,104 | 6,646 | 5,223 |
| TOTAL | $32,857 | $20,565 | $19,977 | $20,286 | $19,183 |
| Total Assets | $534,561 | $494,994 | $500,750 | $376,991 | $376,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 103,498 | 78,641 | 76,375 | 64,789 | 54,543 |
| TOTAL | $117,050 | $90,253 | $86,308 | $80,612 | $65,868 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,281 | 72,129 | 71,984 | 71,845 | 71,708 |
| Other Non-Current Liabilities | 10,148 | 0 | 0 | 0 | 1,240 |
| TOTAL | $82,429 | $72,129 | $71,984 | $71,845 | $72,948 |
| Total Liabilities | $199,479 | $162,382 | $158,292 | $152,457 | $138,816 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,449 | 42,214 | 42,014 | 38,377 | 38,227 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -418,255 | -405,670 | -385,330 | -360,210 | -337,097 |
| Other shareholders' equity | 289 | 39 | 85 | 179 | 346 |
| TOTAL | $335,082 | $332,612 | $342,458 | $224,534 | $237,484 |
| Total Liabilities And Equity | $534,561 | $494,994 | $500,750 | $376,991 | $376,300 |